GYKI-16638 is a novel antiarrhythmic agent that demonstrates combined class IB and class III antiarrhythmic properties in human ventricular muscles, similar to the electrophysiological findings after chronic amiodarone treatment. In addition, GYKI 16638 has an in vivo antiarrhythmic effect comparable to that of D-sotalol.

307556-59-8

C21H31ClN2O5S

459

GYKI 16,638;GYKI16638;GYKI 16638;GYKI-16,638;GYKI16,638;GYKI-16638;GYKI-16638 HCl

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years